About seven months after Boston Scientific (Marlboro, Mass.) obtained approval for the Watchman left atrial appendage closure device (Medical Device Daily, March 17, 2015), the company is now reporting it has gained the FDA nod for another highly anticipated technology, the Synergy bioabsorbable polymer drug-eluting stent system (BP-DES). Read More
